Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 236 | 53 |
| Accounts receivable | -7 | N/A |
| Other Working Capital | 461 | 77 |
| Other Operating Activity | -2,542 | -645 |
| Operating Cash Flow | $-1,852 | $-515 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -56 | -41 |
| Net Acquisitions | N/A | -272 |
| Purchase Of Investment | -17 | -33 |
| Other Investing Activity | -3 | 0 |
| Investing Cash Flow | $-76 | $-346 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 6,490 | 1,208 |
| Other Financing Activity | -146 | 4 |
| Financing Cash Flow | $6,344 | $1,213 |
| Beginning Cash Position | 364 | 0 |
| End Cash Position | 4,780 | 352 |
| Net Cash Flow | $4,416 | $352 |
| Free Cash Flow | ||
| Operating Cash Flow | -1,852 | -515 |
| Capital Expenditure | -56 | -41 |
| Free Cash Flow | -1,908 | -556 |